# Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

> **NCT04266093** · — · ENROLLING_BY_INVITATION · sponsor: **National Cancer Institute (NCI)** · enrollment: 1000 (estimated)

## Conditions studied

- Cervical Intraepithelial Neoplasia
- Cervical Neoplasms
- Oropharyngeal Neoplasms
- Squamous Intraepithelial Lesions of the Cervix
- Hematologic Malignacies

## Interventions

- **DRUG:** GeneTherapy

## Key facts

- **NCT ID:** NCT04266093
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2020-05-08
- **Primary completion:** 2035-10-01
- **Final completion:** 2050-10-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04266093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04266093, "Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04266093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*